- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02194959
Peer Patient Navigation for Colon Cancer Screening
Training African American Peers as Patient Navigators for Colon Cancer Screening
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The overall goal of the study was to reduce CRC morbidity and mortality by increasing African American participation in colonoscopy. This was done by development and implementation of a training program for Peer Patient Navigation (PPN) to increase participation of African Americans in colonoscopy.
The primary care physician referred all participants and introduced the study to the patient. The physician will then introduced the patient to the Research Assistant/Recruiter immediately following the medical visit during which a CRC screening colonoscopy was recommended. The Research Assistant/Recruiter reviewed the study and asked potential participants if they were interested; if so, the candidate's eligibility was determined. If these criteria were met and the patient wanted to be in the study, informed consent and HIPAA was reviewed and obtained. If the patient wanted to think about his/her decision, informed consent was obtained at a later date.
Patients were referred and scheduled for screening colonoscopy as part of standard of care. Both groups received 3 intervention phone calls from their assigned navigators, 1) to schedule the colonoscopy, 2) a call 2 weeks before the procedure and, 3) a third call three days before the procedure.
For research purposes, participants were randomized to one of two kinds of patient navigation:
- Standard patient navigation receiving care that they would normally receive if they were not participating in the study with navigation from the GI staff, and three phone calls involved scheduling and reminding the participant about their colonoscopy appointment.
- Peer Patient Navigation (PPN): Participants were assisted by African American peers who have undergone colonoscopy, and were able to discuss, first-hand, their personal experience undergoing colonoscopy and describe how they coped effectively with the procedure.
PPN's underwent three months of training supervised by study investigators. Multiple modes of training were used (didactic discussion, observation, role-playing, one-on-one sessions, ongoing feedback, rehearsal, supervision via review of audio-tape recording or PPNs and a take-home training manual).
A medical chart review was completed after the colonoscopy for all patients to assess completion of the examination as well as prep quality and any findings where additional clinical follow-up was required. Colonoscopy results were also collected to assess quality of care and measure the effectiveness of PPN navigations compared to standard of care, particularly potential differences based on study group, i.e., compliance.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10029
- ICAHN School of Medicine at Mount Sinai
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Be self-identified as African-American
- Referral from a primary care physician for colonoscopy
- Agree to undergo colonoscopy at a participating hospital
- Be at least 50 years of age or older
- Have telephone service
- Be able to provide informed consent in English
Exclusion Criteria:
- Personal or family history (1st degree relative) of colon cancer
- Personal history of any chronic GI disorder (i.e., irritable bowel syndrome, colitis)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Peer PN
A scheduling phone call will be made to all patients within 14 days of their initial referral to the study.
Following the scheduling of their appointment, each patient will be mailed an informational pamphlet with written instructions for the colonoscopy once they have scheduled the procedure.
The first reminder PPN phone call will be made two weeks before a patient's scheduled colonoscopy.
The second reminder PPN call will be made three days before the scheduled colonoscopy.
For all calls, at least three attempts (at different times of the day and different days of the week) will be made to reach patients.
All telephone calls will be audio-recorded to facilitate fidelity monitoring.
All colonoscopy appointments will be made within the Division of Gastroenterology at each of the hospital sites.
The Project Coordinator will be responsible for confirming completion (and no-shows) for all colonoscopy appointments.
|
Navigation by Peer Patient Navigators
Other Names:
|
|
Active Comparator: Pro PN
Participants randomized to standard patient navigation received care that they would normally receive if they were not participating in the study with navigation from the GI staff, and three phone calls that involved scheduling and reminding the participant about their colonoscopy appointment.
|
Navigation by Standard Hospital Navigators
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Colonoscopy completion
Time Frame: up to 6 months
|
up to 6 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GCO 07-0594
- 5R25CA132692-05 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Screening Colonoscopy
-
Borland-Groover ClinicValley Medical Products, LLC is paying for the study and is the sponsor....CompletedColonoscopy | Screening Colonoscopy | Surveillance ColonoscopyUnited States
-
HyGIeaCare, Inc.MedtronicCompletedScreening ColonoscopyUnited States
-
University of Colorado, DenverThe Henry J. Kaiser Family FoundationCompletedColonoscopy | Mass ScreeningUnited States
-
Konkuk University Medical CenterGlaxoSmithKlineCompletedDiagnostic Colonoscopy ScreeningKorea, Republic of
-
GI View Ltd.Terminated
-
Morehouse School of MedicineRecruitingColorectal Cancer Screening | Bowel Cleansing for ColonoscopyUnited States
-
Medical College of WisconsinWithdrawnPatients Undergoing Screening or Surveillance ColonoscopyUnited States
-
Magentiq Eye LTDCompletedScreening Colonoscopy | Surveillance ColonoscopyUnited States, Israel, Germany, Netherlands
-
Nanfang Hospital, Southern Medical UniversityRecruitingBowel Preparation Solutions | Colonoscopy | Colorectal Cancer ScreeningChina
-
Magentiq Eye LTDNot yet recruitingScreening Colonoscopy | Surveillance ColonoscopyIsrael, United States, Netherlands
Clinical Trials on Peer PN
-
Icahn School of Medicine at Mount SinaiCompleted
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA); University of Wisconsin, MadisonCompletedHIV | Drug UseUnited States
-
University of New MexicoWithdrawnKidney Diseases | Social Determinants of Health
-
University of New MexicoUniversity of Pittsburgh; Case Western Reserve University; University of Massachusetts...Active, not recruiting
-
The University of Texas Health Science Center at...Susan G. Komen Breast Cancer FoundationCompleted
-
The University of Texas Health Science Center at...National Cancer Institute (NCI)CompletedBreast Cancer | Colorectal Cancer | Prostate CancerUnited States
-
PfizerCompletedNeoplasms | Multiple Myeloma | Lymphoma, Malignant | ThrombocytopeniaUnited States, Argentina, Mexico
-
Janssen Research & Development, LLCCompleted
-
PfizerCompletedSarcomaUnited States
-
Janssen Research & Development, LLCCompletedPlaque PsoriasisUnited States, Canada, Germany, France, Spain, Poland